Development of a Genetic Assay to Distinguish between Leishmania viannia Species on the Basis of Isoenzyme Differences
Open Access
- 15 March 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (6) , 801-809
- https://doi.org/10.1086/500326
Abstract
Background. Tegumentary leishmaniasis in Latin America is caused mainly by Leishmania viannia braziliensis complex parasites. L. braziliensis and Leishmania viannia peruviana are the 2 predominant Leishmania species in Peru. L. braziliensis is more virulent, because it can cause mucocutaneous leishmaniasis, known as espundia, that results in severe facial destruction. Early identification of the species that causes the initial cutaneous infection would greatly help to prevent mucocutaneous leishmaniasis, because it would allow more aggressive treatment and follow-up. However, because of the close genetic similarity of L. braziliensis and L. peruviana, there currently exists no simple assay to distinguish between these species. Methods. We cloned the mannose phosphate isomerase gene from both L. braziliensis and L. peruviana. It is the only known isoenzyme capable of differentiating between L. braziliensis and L. peruviana in multilocus enzyme electrophoresis. Interestingly, only a single nucleotide polymorphism was found between the mannose phosphate isomerase genes from L. braziliensis and L. peruviana, resulting in an amino acid change from threonine to arginine at amino acid 361. A polymerase chain reaction assay was developed to distinguish the single nucleotide polymorphism of the mannose phosphate isomerase gene to allow for the specific identification of L. braziliensis or L. peruviana. Results. This assay was validated with 31 reference strains that were previously typed by multilocus enzyme electrophoresis, successfully applied to patient biopsy samples, and adapted to a real-time polymerase chain reaction assay. Conclusions. This innovative approach combines new genetic knowledge with traditional biochemical fundamentals of multilocus enzyme electrophoresis to better manage leishmaniasis in Latin America.Keywords
This publication has 16 references indexed in Scilit:
- Randomized, Double-Blind Clinical Trial of Topical Imiquimod 5% with Parenteral Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis in PeruClinical Infectious Diseases, 2005
- New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellersQJM: An International Journal of Medicine, 2004
- Direct identification of Leishmania species in biopsies from patients with American tegumentary leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 2003
- Successful Treatment of Drug‐Resistant Cutaneous Leishmaniasis in Humans by Use of Imiquimod, an ImmunomodulatorClinical Infectious Diseases, 2001
- LeishmaniasisThe Lancet, 1999
- The Developmental Expression of A2 Amastigote-specific Genes Is Post-transcriptionally Mediated and Involves Elements Located in the 3′-Untranslated RegionJournal of Biological Chemistry, 1996
- Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunityEpidemiology and Infection, 1995
- Rapid isolation of DNA from trypanosomatid protozoa using a simple ‘mini-prep’ procedureMolecular and Biochemical Parasitology, 1993
- Biochemical characterization of Leishmania (Viannia) braziliensis and Leishmania (Viannia) peruviana by isoenzyme electrophoresisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Characterization of Leishmania species from PeruTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987